Jefferies Group’s Fortress Biotech FBIO Stock Holding History

Jefferies Group’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-1,667	Closed	-$175K	–	2004
2013 Q3	$175K	Buy	+1,667	New	+$204K	﹤0.01%	1640

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jefferies Group's FBIO Position: Q2 2020 in Review

Jefferies Group sold out of Fortress Biotech (FBIO) in Q2 2020, closing a stake of 760 shares — an estimated $22K sold.

Jefferies Group first reported a position in FBIO in Q2 2013 and held it in 7 quarters. The position peaked at $681K in Q4 2013. 73 funds tracked by Wall St. Rank hold FBIO as of Q2 2020.

Jefferies Group reported no remaining Fortress Biotech position as of Q2 2020 after selling out during the quarter.
Jefferies Group sold 760 Fortress Biotech shares in Q2 2020, an estimated $22K.
Jefferies Group first reported a position in Fortress Biotech in Q2 2013 and held it in 7 quarters.
Jefferies Group's Fortress Biotech position peaked at $681K in Q4 2013.
73 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2020.

Based on Jefferies Group's 13F filing for Q2 2020, filed 14 Aug 2020.